Spero Therapeutics to Participate in the Chardan 10th Annual Healthcare Conference
Key Highlights
- ➤Spero CEO Esther Rajavelu to join Chardan healthcare conference fireside chat October 20
- ➤Spero leadership team available for one-on-one meetings at the conference
- ➤SP001 advanced in IgG4-related disease as Spero’s lead clinical program
Expert Statements
Esther Rajavelu, President and Chief Executive Officer of Spero Therapeutics
“Esther Rajavelu, Spero's President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10th Annual Healthcare Conference”
CAMBRIDGE, Mass., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a clinical-stage biopharmaceutical company focused on advancing next-generation medicines in immunology and inflammation, today announced that Esther Rajavelu, Spero's President and Chief Executive Officer, will participate in a fireside chat at the Chardan 10(th) Annual Healthcare Conference to be held in New York City, on October 20(th), 2026. Spero's leadership team will also be available for one-on-one meetings at the conference.
Presentation Details Date / time: October 20, 2026, 9:15 AM ET Format: Fireside chat Location: Holmes II, Lotte New York Palace Webcast Link Here
Get started
Create a free account to read the full story.